You just read:

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

News provided by

Boston Scientific Corporation

31 Oct, 2012, 12:00 GMT